Detalhe da pesquisa
1.
The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors.
Eur J Nucl Med Mol Imaging
; 51(3): 828-840, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947850
2.
The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study.
Eur J Nucl Med Mol Imaging
; 51(3): 852-861, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803246
3.
Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.
Clin Exp Rheumatol
; 42(2): 358-366, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293968
4.
Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis.
Turk J Med Sci
; 54(1): 69-75, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38812633
5.
Demonstration of in vivo estrogen receptor status with 16α- [18F]fluoro-17ß-oestradiol (FES) PET/CT in a rare case of benign metastasizing leiomyoma.
Eur J Nucl Med Mol Imaging
; 48(12): 4101-4102, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031720
6.
The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage.
Cancer Biother Radiopharm
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484307
7.
Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90Y Selective Internal Radiation Therapy Planning.
Cancer Biother Radiopharm
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265813
8.
An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatment dosimetry.
Radiat Prot Dosimetry
; 199(12): 1274-1283, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334429
9.
Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score's prediction factor for survival?
Hepatol Forum
; 4(3): 103-107, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822305
10.
Role of red blood cell scintigraphy for determining the localization of gastrointestinal bleeding.
Ulus Travma Acil Cerrahi Derg
; 18(3): 225-30, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22864714
11.
68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes.
Clin Nucl Med
; 47(1): e45-e46, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34284482
12.
Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on 18F-FDG, 68Ga-DOTATATE, and 68Ga-FAPI04 PET/CT.
Clin Nucl Med
; 47(1): e79-e80, 2022 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392280
13.
Outcome of 177 Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters : A Single-Center Experience.
Clin Nucl Med
; 47(8): e521-e528, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543629
14.
Comparison of 2D planar and 3D volumetric methods for estimation of split renal function by 99mTc-DMSA scintigraphy.
Phys Med
; 95: 83-88, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134649
15.
Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA.
Ann Nucl Med
; 36(1): 52-60, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648169
16.
An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 (177Lu)-DOTATATE.
Cancer Biother Radiopharm
; 37(1): 17-22, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134512
17.
The Role of FDG Positron Emission Tomography/Contrast--Enhanced Computed Tomography in Preoperative Staging and Postoperative Follow-up in Rectal Cancer Surgery.
Pol Przegl Chir
; 94(6): 10-16, 2022 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468505
18.
225Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: A Single-Center Experience.
Clin Nucl Med
; 46(12): 943-951, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593693
19.
Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04.
Clin Nucl Med
; 46(8): 641-646, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33883494
20.
Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?
Ann Nucl Med
; 35(6): 680-690, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783752